Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized cholic acid trial for bile acid synthesis defects
NL-OMON59802Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cholic acid in Bile Acid Synthesis Defects (BASD) and Zellweger spectrum disorder (PBD-ZSD), sponsored by Amsterdam University Medical Center. Primary endpoints: Suppression of endogenous bile acid synthesis, Adverse events and 1 more. Started Jun 2020; status: completed.
02
Drugs
cholic acid
03
Conditions
Bile Acid Synthesis Defects (BASD)Zellweger spectrum disorder (PBD-ZSD)
Beyond the preview
Go deeper on NL-OMON59802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59802.